Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvin Reichman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nature Reviews. Drug Discovery|January 1, 2014
Opening the lead generation toolboxPeter B Simpson, Melvin Reichman
Drug Discovery Today|January 9, 2016
Open innovation in early drug discovery: roadmaps and roadblocksMelvin Reichman, Peter B Simpson
Assay and Drug Development Technologies|May 3, 2016
Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET SignalThomas Zielinski, Melvin Reichman, Preston S Donover, et al.
Journal of Biomolecular Screening|October 9, 2010
Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1Scott Thompson, Troy Messick, David C Schultz, et al.
Journal of Biomolecular Screening|July 22, 2015
A High-Throughput Assay for Rho Guanine Nucleotide Exchange Factors Based on the Transcreener GDP AssayMelvin Reichman, Amanda Schabdach, Meera Kumar, et al.
Combinatorial Chemistry & High Throughput Screening|September 1, 2012
New informatics and automated infrastructure to accelerate new leads discovery by high throughput screening (HTS)Preston S Donover, Marlin Yohn, Matthew Sim, et al.
ACS Chemical Biology|May 24, 2014
Identification and characterization of small molecule human papillomavirus E6 inhibitorsKimberly A Malecka, Daniela Fera, David C Schultz, et al.
Plos One|March 4, 2014
Meglumine exerts protective effects against features of metabolic syndrome and type II diabetesArturo Bravo-Nuevo, Alice Marcy, Minzhou Huang, et al.
Chemistry & Biology|April 24, 2012
Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteinsDaniela Fera, David C Schultz, Santosh Hodawadekar, et al.
Journal of Cellular Biochemistry|February 28, 2019
Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumineKaylend Manley, Arturo Bravo-Nuevo, Allyson R Minton, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nature Reviews. Drug Discovery|January 1, 2014
Opening the lead generation toolboxPeter B Simpson, Melvin Reichman
Drug Discovery Today|January 9, 2016
Open innovation in early drug discovery: roadmaps and roadblocksMelvin Reichman, Peter B Simpson
Assay and Drug Development Technologies|May 3, 2016
Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET SignalThomas Zielinski, Melvin Reichman, Preston S Donover, et al.
Journal of Biomolecular Screening|October 9, 2010
Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1Scott Thompson, Troy Messick, David C Schultz, et al.
Journal of Biomolecular Screening|July 22, 2015
A High-Throughput Assay for Rho Guanine Nucleotide Exchange Factors Based on the Transcreener GDP AssayMelvin Reichman, Amanda Schabdach, Meera Kumar, et al.
Combinatorial Chemistry & High Throughput Screening|September 1, 2012
New informatics and automated infrastructure to accelerate new leads discovery by high throughput screening (HTS)Preston S Donover, Marlin Yohn, Matthew Sim, et al.
ACS Chemical Biology|May 24, 2014
Identification and characterization of small molecule human papillomavirus E6 inhibitorsKimberly A Malecka, Daniela Fera, David C Schultz, et al.
Plos One|March 4, 2014
Meglumine exerts protective effects against features of metabolic syndrome and type II diabetesArturo Bravo-Nuevo, Alice Marcy, Minzhou Huang, et al.
Chemistry & Biology|April 24, 2012
Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteinsDaniela Fera, David C Schultz, Santosh Hodawadekar, et al.
Journal of Cellular Biochemistry|February 28, 2019
Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumineKaylend Manley, Arturo Bravo-Nuevo, Allyson R Minton, et al.
Pageof 2